Commercializing Bioprinting

The difficulties with commercialization or clinical translation in the realm of bioprinting are numerous and varied.

The existing difficulties in the therapeutic application of 3D bioprinted human tissues were well-described in a recent review.

Maintaining the cells without causing them any harm throughout the drawn-out printing process would be a difficulty connected to scalability (producing human scale tissues and organs).

<p>New bioprinting techniques mentioned in the text include tomographic volumetric bioprinting and the freeform reversible embedding of suspended hydrogels.</p> Signup and view all the answers

<p>The purpose of in situ monitoring of the printing process is to ensure the proper execution and progress of the bioprinting process.</p> Signup and view all the answers